Baylor College of Medicine

BAT IT: Banked Anti-SARS Cov-2 T cell Infusions for Treatment of COVID 19 (H-47739)

Description

Content

BAT IT: Banked Anti-SARS Cov-2 T cell Infusions for Treatment of COVID 19

This is a dose-finding safety trial followed by a randomized pilot trial comparing administration of SARS-CoV2-specific T cells (SARS-CoVSTs) to standard of care treatment in hospitalized patients with COVID19 who are at high risk of requiring mechanical ventilation.

The SARS-CoVSTs lines have been made at Baylor College of Medicine from healthy donors who have made a full recovery from COVID19. These cell lines were frozen for later use and will be thawed and used to treat patients who meet the eligibility criteria.

AGE REQUIREMENTS:  18 years and older.

More information about this study can be found on clinicaltrials.gov.

NCT#/ClinicalTrials.gov ID:04401410
 

Contact

Kimberly McGee Mooney

Phone 1: 832–275–0194

IRB: H-47739

Status:

Active

Created:

Back to topback-to-top